Literature DB >> 17602232

A model of cerebral aspergillosis in non-immunosuppressed nursing rats.

Stefan Zimmerli1, Urspeter Knecht, Stephen L Leib.   

Abstract

Central nervous system aspergillosis is an often fatal complication of invasive Aspergillus infection. Relevant disease models are needed to study the pathophysiology of cerebral aspergillosis and to develop novel therapeutic approaches. This study presents a model of central nervous system aspergillosis that mimics important aspects of human disease. Eleven-day-old non-immunosuppressed male Wistar rats were infected by an intracisternal injection of 10 mul of a conidial suspension of Aspergillus fumigatus. An inoculum of 7.18 log(10) colony-forming units (CFU) consistently produced cerebral infection and resulted in death of all animals (n = 25) within 3-10 days. Median survival time was 3 days. Histomorphologically, all animals developed intracerebral abscesses (2-26 per brain) containing abundant fungal hyphae and neutrophils. Fungal culture of cortical homogenates yielded maximal growth on day 3 after infection (5.4 log(10) CFU/g, n = 15) that declined over time. Galactomannan concentrations in cortical homogenates, assessed as an index for hyphal burden, peaked on days 3-5. Fungal infection spread to peripheral organs in 83% of animals. Fungal burden in lung, liver, spleen and kidney was two orders of magnitude lower than in the brain. The successful establishment of a model of cerebral aspergillosis in a non-immunosuppressed host provides the opportunity to investigate mechanisms of disease and to develop novel treatment regimens for this commonly fatal infection.

Entities:  

Mesh:

Year:  2007        PMID: 17602232     DOI: 10.1007/s00401-007-0255-0

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  8 in total

1.  Real-time treatment guidelines: considerations during the Exserohilum rostratum outbreak in the United States.

Authors:  Peter G Pappas; Dimitrios P Kontoyiannis; John R Perfect; Tom M Chiller
Journal:  Antimicrob Agents Chemother       Date:  2013-02-05       Impact factor: 5.191

Review 2.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

Review 3.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

4.  Caspofungin Cerebral Penetration and Therapeutic Efficacy in Experimental Cerebral Aspergillosis.

Authors:  Irina Ullmann; Andrea Aregger; Stephen L Leib; Stefan Zimmerli
Journal:  Microbiol Spectr       Date:  2022-04-18

5.  RNAseq analysis of Aspergillus fumigatus in blood reveals a just wait and see resting stage behavior.

Authors:  Henriette Irmer; Sonia Tarazona; Christoph Sasse; Patrick Olbermann; Jürgen Loeffler; Sven Krappmann; Ana Conesa; Gerhard H Braus
Journal:  BMC Genomics       Date:  2015-08-27       Impact factor: 3.969

6.  A diagnostic riddle in an immunocompetent adult: Meningioma or intracranial fungal granuloma?

Authors:  Syed A Ali; Anita Jagetia; Kavita Gaur; Puja Sakhuja
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

Review 7.  Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Front Microbiol       Date:  2017-05-16       Impact factor: 5.640

8.  Protective Efficacy of Lectin-Fc(IgG) Fusion Proteins In Vitro and in a Pulmonary Aspergillosis In Vivo Model.

Authors:  Claudia Rodriguez-de la Noval; Susana Ruiz Mendoza; Diego de Souza Gonçalves; Marina da Silva Ferreira; Leandro Honorato; José Mauro Peralta; Leonardo Nimrichter; Allan J Guimarães
Journal:  J Fungi (Basel)       Date:  2020-10-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.